Gamma Wave Therapy for Traumatic Brain Injury
(DAGABBI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment using sound waves to aid veterans with cognitive and emotional issues after exposure to explosions. The goal is to determine if these sound waves can enhance brain function and aid recovery. Veterans exposed to blasts from less than 10 meters away or more than 10 meters away might qualify to participate. The researchers aim to develop better treatments for blast-related brain injuries. As an unphased study, this trial offers veterans a unique chance to contribute to groundbreaking research that could improve recovery methods for such injuries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that auditory gamma sensory stimulation is safe for treating traumatic brain injury?
Research has shown that using sound waves, known as auditory gamma sensory stimulation, is generally safe. In studies with healthy adults, participants listened to sounds at frequencies such as 40 Hz and 60 Hz, and these studies found no significant harmful effects. Similar methods have improved thinking skills in people with dementia, further supporting its safety. Although more research is needed to fully understand its effects, current evidence suggests that this type of sound therapy is well-tolerated, with few side effects reported.12345
Why are researchers excited about this trial?
Researchers are excited about auditory gamma sensory stimulation for traumatic brain injury because it offers a novel, non-invasive approach to treatment. Unlike standard care options, which may include medications to manage symptoms or therapies to support recovery, this method leverages sound waves to stimulate brain activity. By targeting gamma waves, which are thought to play a role in brain repair and cognitive functions, this therapy could potentially enhance healing and improve outcomes for patients in a way that current treatments do not.
What evidence suggests that auditory gamma sensory stimulation is effective for traumatic brain injury?
Research shows that sound waves, specifically at 40 Hz, might improve brain function. Studies have found that this sound can create brain wave patterns linked to enhanced thinking and memory. Another study found that this sound helps different parts of the brain work together more effectively. In some cases, using these sound waves over time has been linked to maintaining mental sharpness and improving mood. While researchers are still learning about its effects on brain injuries from blasts, these findings suggest that this sound therapy, provided to all participants in this trial as auditory gamma sensory stimulation, could assist Veterans with cognitive and emotional challenges following such injuries.23678
Who Is on the Research Team?
Kevin M. Spencer, PhD
Principal Investigator
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Are You a Good Fit for This Trial?
This trial is for post-9/11 combat veterans aged 18-65 who have experienced blast exposure and are part of the VA Boston Healthcare System. It includes those exposed to blasts from less than or more than 10 meters away, with groups matched by age and gender. Veterans must not have severe mental health issues, neurological illnesses, substance abuse problems, or hearing impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive auditory gamma sensory stimulation to assess and remediate gamma oscillation abnormalities
Follow-up
Participants are monitored for changes in gamma power and cognitive function after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Auditory gamma sensory stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor